194 related articles for article (PubMed ID: 17178668)
21. [Evaluation of red cell mean corpuscular volume and simple tube red cell osmotic fragility quantitative test in detection of thalassemia].
Deng J; Liu X; Liu Y
Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):610-2. PubMed ID: 11372413
[TBL] [Abstract][Full Text] [Related]
22. Can Couples With MCV≥80, MCH<26, HbA2<3.2, HbF<3 be Classified as Low-risk β-Thalassemia Group?
Mirzakhani M; Tarrahi MJ; Baghersad A; Maracy MR
J Pediatr Hematol Oncol; 2019 May; 41(4):303-306. PubMed ID: 30676434
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and some epidemiological factors of beta thalassaemia trait in Sindhi community of Nagpur City, India.
Mulchandani DV; Fulare MB; Zodpey SP; Vasudeo ND
Indian J Public Health; 2008; 52(1):11-5. PubMed ID: 18700715
[TBL] [Abstract][Full Text] [Related]
24. NESTROFT-A Cost-Effective Mass Screening Tool for the Detection of β-Thalassemia Carrier Status in Anemic Pregnant Women: A Step Toward Reducing the National Disease Burden.
Gosavi M; Chavan R; Bellad MB
J Lab Physicians; 2021 Dec; 13(4):368-373. PubMed ID: 34975258
[No Abstract] [Full Text] [Related]
25. Prevalence of β thalassemia carrier state in Sindhi community of Wardha and evaluation of risk factors for β thalassemia trait.
Rakholia R; Chaturvedi P
Niger J Clin Pract; 2013; 16(3):375-80. PubMed ID: 23771465
[TBL] [Abstract][Full Text] [Related]
26. Efficiency of premarital screening of beta-thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran.
Karimi M; Rasekhi AR
Haematologia (Budap); 2002; 32(2):129-33. PubMed ID: 12412732
[TBL] [Abstract][Full Text] [Related]
27. NESTROFT: a screening test for beta thalassemia trait.
Mehta BC
Indian J Med Sci; 2002 Nov; 56(11):537-45. PubMed ID: 14510336
[No Abstract] [Full Text] [Related]
28. Sensitivity and specificity of simple erythrocyte osmotic fragility test for screening of alpha-thalassemia-1 and Beta-thalassemia trait in pregnant women.
Tongprasert F; Sirichotiyakul S; Piyamongkol W; Tongsong T
Gynecol Obstet Invest; 2010; 69(4):217-220. PubMed ID: 20068326
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and hematological characteristics of beta-thalassemia trait in Gaziantep urban area, Turkey.
Gurbak M; Sivasli E; Coskun Y; Bozkurt AI; Ergin A
Pediatr Hematol Oncol; 2006; 23(5):419-25. PubMed ID: 16728362
[TBL] [Abstract][Full Text] [Related]
30. [Values of MCV,MCH,ROFT and HbA
Liu Y; Lin XY; Huang Y; Huang QW; Chen HL; Shen MN; Ruan JY; Li XY; Xu LH; Fang JP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1679-1682. PubMed ID: 33067973
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of the effect of three β-thalassemia prenatal screening strategies using in Guangdong province].
Li B; Yin A; Luo M; Wu L; Ma Y; Wang X; Zhang X; Zhao Q
Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):434-40. PubMed ID: 26311551
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity and specificity of mean corpuscular volume testing for screening for alpha-thalassemia-1 and beta-thalassemia traits.
Sirichotiyakul S; Maneerat J; Sa-nguansermsri T; Dhananjayanonda P; Tongsong T
J Obstet Gynaecol Res; 2005 Jun; 31(3):198-201. PubMed ID: 15916654
[TBL] [Abstract][Full Text] [Related]
33. Hemoglobinopathy Screening by Osmotic Fragility Test Based on Flow Cytometer or Naked Eye.
Mohapatra R; Warang P; Ghosh K; Colah R
Cytometry B Clin Cytom; 2014 Nov; ():. PubMed ID: 25421017
[TBL] [Abstract][Full Text] [Related]
34. Screening of Extended Family Members of Thalassemia Major Children as a Thalassemia Preventive Strategy.
Sonkawade ND; Kinikar AA; Kulkarni RK; Dawre RM; Valvi CT; Kamath PA
Ethiop J Health Sci; 2022 Nov; 32(6):1203-1210. PubMed ID: 36475260
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of beta-thalassaemia in subcastes of Indian Sindhis: Results from a two-phase survey.
Jawahirani A; Mamtani M; Das K; Rughwani V; Kulkarni H
Public Health; 2007 Mar; 121(3):193-8. PubMed ID: 17196230
[TBL] [Abstract][Full Text] [Related]
36. Effect of antiretroviral therapy on hemoglobin A2 values can have implications in antenatal beta-thalassemia screening programs.
Bhagat P; Kaur Sachdeva R; Sharma P; Updesh Singh Sachdeva M; Chhabra S; Sharma A; Das R
Infect Dis (Lond); 2016 Feb; 48(2):122-6. PubMed ID: 26431373
[TBL] [Abstract][Full Text] [Related]
37. New analytical tools and epidemiological data for the identification of HbA2 borderline subjects in the screening for beta-thalassemia.
Mosca A; Paleari R; Galanello R; Sollaino C; Perseu L; Demartis FR; Passarello C; Giambona A; Maggio A;
Bioelectrochemistry; 2008 Aug; 73(2):137-40. PubMed ID: 18486569
[TBL] [Abstract][Full Text] [Related]
38. Impact of iron deficiency on hemoglobin A2% in obligate β-thalassemia heterozygotes.
Sharma P; Das R; Trehan A; Bansal D; Chhabra S; Kaur J; Marwaha RK; Varma N; Garewal G
Int J Lab Hematol; 2015 Feb; 37(1):105-11. PubMed ID: 24754744
[TBL] [Abstract][Full Text] [Related]
39. Nestroft screening tool for beta-thalassemia trait.
Sharma U; Agrawal AK; Choudhary A; Sitaraman S; Sharma ML
Indian Pediatr; 1996 Sep; 33(9):788-9. PubMed ID: 9057414
[No Abstract] [Full Text] [Related]
40. Sensitivity and specificity of single-tube osmotic fragility test and its different methods as screening test for thalassemia trait: an alternative to expensive laboratory tests for resource-limited countries.
Ansari SH; Hanifa A; Saleem A; Ali SM; Hussain Z; Zohaib M; Akbar M; Rehman S; Hussain SR
Eur J Haematol; 2014 Dec; 93(6):516-20. PubMed ID: 24912950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
